Get started
Author

Rita Wen Kaspar

Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity
2008 · James C Dodge, Amanda M Haidet, et al. · Molecular Therapy · 160
PDF
Analysis of Dystrophin Deletion Mutations Predicts Age of Cardiomyopathy Onset in Becker Muscular Dystrophy
2009 · Rita Wen Kaspar, Hugh D. Allen, et al. · Circulation Cardiovascular Genetics · 157
Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy
2009 · Rita Wen Kaspar, Hugh D. Allen, et al. · Journal of the American Academy of Nurse Practitioners · 88
AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS
2009 · Mark Hester, Kevin Foust, et al. · Current Gene Therapy · 51
Strategies to Promote Cultural Competence in Distance Education
2014 · Megan Arbour, Rita W. Kaspar, et al. · Journal of Transcultural Nursing · 37
Efficient method for site-directed mutagenesis in large plasmids without subcloning
2017 · Louay K. Hallak, Kelly Berger, et al. · PLoS ONE · 10
PDF
Gene Therapy and Informed Consent Decision Making: Nursing Research Directions
2009 · Rita W. Kaspar, Celia E. Wills, et al. · Biological Research For Nursing · 2
Response to Letter by Yilmaz et al Regarding Article, “Analysis of Dystrophin Deletion Mutations Predicts Age of Cardiomyopathy Onset in Becker Muscular Dystrophy”
2010 · Federica Montanaro, Hugh D. Allen, et al. · Circulation Cardiovascular Genetics · 1
PDF
Genotype-phenotype association analysis of dilated cardiomyopathy in Becker muscular dystrophy
2009 · Rita Wen Kaspar · OhioLink ETD Center (Ohio Library and Information Network)
PDF
Works count: 9
Citation count: 506
H-index: 6
I10-index: 6
Year
Topic
Type